(6R)-6-[(3R,5S,7R,10S,13R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptanoic acid
生物活性 用途与合成方法 MSDS (6R)-6-[(3R,5S,7R,10S,13R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptanoic acid价格(试剂级) 上下游产品信息
| 中文名称 | (6R)-6-[(3R,5S,7R,10S,13R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptanoic acid |
|---|---|
| 中文同义词 | 3Α,7Α-DIHYDROXYCOPROSTANIC ACID;3Α,7Α-二羟基粪烯酸;三Α,7Α-二羟COPROSTANIC酸 |
| 英文名称 | (6R)-6-[(3R,5S,7R,10S,13R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptanoic acid |
| 英文同义词 | (6R)-6-[(3R,5S,7R,10S,13R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptanoic acid;3α,7α-Dihydroxy-5β-cholest-26-oic acid;3α,7α-Dihydroxy-5β-cholestan-26-oic acid;3a,7a-Dihydroxycoprostanic acid;(25RS)-3α,7α-dihydroxy-5β-cholestan-26-oic acid;3α,7α-Dihydroxycoprostanic Acid;-DihydroxycoprostanicAcid;3α,7α-Dihydroxycoprostanic acid |
| CAS号 | 17974-66-2 |
| 分子式 | C27H46O4 |
| 分子量 | 0 |
| EINECS号 | |
| 相关类别 | 对照品 |
| Mol文件 | 17974-66-2.mol |
| 结构式 | ![(6R)-6-[(3R,5S,7R,10S,13R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptanoic acid 结构式](CAS/GIF/17974-66-2.gif) |
(6R)-6-[(3R,5S,7R,10S,13R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptanoic acid 性质
| 溶解度 | 可溶于氯仿（少许）、甲醇（少许） |
|---|---|
| 形态 | 固体 |
| 颜色 | 白色至类白色 |
(6R)-6-[(3R,5S,7R,10S,13R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptanoic acid 用途与合成方法
3α,7α-Dihydroxycoprostanic acid 是一种内源性代谢物，是一种胆汁酸，是鹅去氧胆酸的前体。
安全信息
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2022/04/29 | HY-113097 | (6R)-6-[(3R,5S,7R,10S,13R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptanoic acid 3α,7α-Dihydroxycoprostanic acid | 17974-66-2 | 5mg | 8500元 |
| 2022/04/29 | HY-113097 | (6R)-6-[(3R,5S,7R,10S,13R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptanoic acid 3α,7α-Dihydroxycoprostanic acid | 17974-66-2 | 10mg | 13600元 |